Skip to main content

FDA announces recall of Abbott neurostimulation devices after MRI-related issues lead to 73 injuries

By Health Imaging  
   September 15, 2023

The U.S. Food and Drug Administration (FDA) has announced that Abbott is recalling some of its Proclaim and Infinity neurostimulation systems due to an ongoing issue with patients being unable to exit MRI mode. This is a Class I recall, which means the FDA has determined the use of these devices “may cause serious injuries or death.”

Full story


Get the latest on healthcare leadership in your inbox.